Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $1.9 billion.

  • Dexcom's Accounts Payables rose 2264.21% to $1.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.9 billion, marking a year-over-year increase of 2264.21%. This contributed to the annual value of $1.9 billion for FY2025, which is 2264.21% up from last year.
  • Latest data reveals that Dexcom reported Accounts Payables of $1.9 billion as of Q4 2025, which was up 2264.21% from $1.9 billion recorded in Q3 2025.
  • Dexcom's 5-year Accounts Payables high stood at $1.9 billion for Q4 2025, and its period low was $482.0 million during Q2 2021.
  • Over the past 5 years, Dexcom's median Accounts Payables value was $1.3 billion (recorded in 2023), while the average stood at $1.2 billion.
  • Per our database at Business Quant, Dexcom's Accounts Payables surged by 8788.79% in 2021 and then soared by 1597.84% in 2024.
  • Over the past 5 years, Dexcom's Accounts Payables (Quarter) stood at $573.0 million in 2021, then surged by 57.38% to $901.8 million in 2022, then soared by 49.2% to $1.3 billion in 2023, then rose by 17.81% to $1.6 billion in 2024, then rose by 22.64% to $1.9 billion in 2025.
  • Its last three reported values are $1.9 billion in Q4 2025, $1.9 billion for Q3 2025, and $1.9 billion during Q2 2025.